Description
Food complement in enteric release orosoluble bags based on FERNANO, an innovative raw material made up of ultramicronized microencapsulated bisglycinate iron.
The product contains 30 mg of iron each bag. Iron contributes to normal cognitive function, normal energy metabolism, normal formation of red blood cells and hemoglobin, normal oxygen transport in the body, normal function of the immune system, reduction of fatigue and fatigue, also intervenes in the process of division of cells.
The Bisferr++, thanks to the sophisticated FERNANO technology, contains ultra-micronized bisglycinate iron micro-completes that allow the iron to be released only at the level of the intestinal tract, ensuring:
- high absorption and intestinal bioavailability of iron, advantage obtained through dimensional reduction of microencapsulated by means of ULTRAMICRO technology;
- greater digestibility and excellent tolerance. Benefits guaranteed by the microencapsulation process that through a polymer coating membrane protects the Iron and avoids gastrointestinal problems, eliminates the aftertaste and metallic smell.

Ingredients
FERNANO (Ferro bisglycinate ultramicronizzato microencapsulato); sweeteners: mannitol, sucralose; acidifier: citric acid; aroma; anti-agglomerating agent: silicon dioxide.

Nutritional characteristics

Average content	for 1 bag	VNR
Iron	30 mg	214

*VNR=Nutritive Reference Value.

Mode of use
It is recommended to take 1 sachet per day directly in the mouth.

Warnings
Supplements should not be understood as substitutes for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age.
Excessive consumption can have laxative effects.

Conservation
Store in a cool and dry place.

Format
14 sachets from 1.5 g.
Net weight: 21 g.

Cod. 942142074

Bibliography:
Iron monograph. Pdr tor Nutrional supplements, First Edition. Thomson POR Staff. 2001. pp 235-240. Iron monograph. POR Nutritional Supplements. New Edition. s. Hendler, o. Jorvik. 2010. pp 247-253. Opinion of the Scientific Committee/Scientific Panel. Iron and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 [8 pp]. M. Auerbach, H. Ballard, J. R. Trout, M. Mcllwain, A. Ackerman. H. Bahrain, et al. lntravenous optimize Irons the Response to Recombinant Human Erythropoietin in Cancer Patients With hemotherapy-Related Anemia: A Multicenter. Open-Label. Randomized Trial. J Clin Oncol. 2004; 22 (7): 1301-7. s. Samman. Iron. Nutrition & Oletetics 2007; 64 (Suppl. 4): S126- S130. J.L. Spivak, P. Gasc6n, H. Ludwig. Anemia Management In Oncology And Hematology. The Oncologist 2009; 14 (Suppl. 1): 43-56 www.theoncologist.com.